KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Deferred Taxes (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Deferred Taxes for 17 consecutive years, with -$13.0 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 138.24% to -$13.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105.0 million through Dec 2025, up 707.69% year-over-year, with the annual reading at $105.0 million for FY2025, 707.69% up from the prior year.
  • Deferred Taxes hit -$13.0 million in Q4 2025 for Quest Diagnostics, down from $110.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $110.0 million in Q3 2025 to a low of -$44.0 million in Q4 2022.
  • Historically, Deferred Taxes has averaged $7.8 million across 5 years, with a median of -$1.5 million in 2023.
  • Biggest five-year swings in Deferred Taxes: skyrocketed 3150.0% in 2022 and later tumbled 350.0% in 2024.
  • Year by year, Deferred Taxes stood at $30.0 million in 2021, then crashed by 246.67% to -$44.0 million in 2022, then soared by 77.27% to -$10.0 million in 2023, then skyrocketed by 440.0% to $34.0 million in 2024, then crashed by 138.24% to -$13.0 million in 2025.
  • Business Quant data shows Deferred Taxes for DGX at -$13.0 million in Q4 2025, $110.0 million in Q3 2025, and $1.0 million in Q2 2025.